Affiliations 

  • 1 Advanced Medical and Dental Institute, Universiti Sains Malaysia, Bertam, Penang, Malaysia
  • 2 Institute of Experimental Pathology (ZMBE), University of Münster, Münster, Germany
  • 3 Faculty of Veterinary Medicine, Universiti Malaysia Kelantan, Kelantan, Malaysia
  • 4 Medical Faculty, Transgenic Animal and Genetic Engineering Models (TRAM), University of Münster, Münster, Germany
Am J Trop Med Hyg, 2019 06;100(6):1328-1334.
PMID: 30963989 DOI: 10.4269/ajtmh.18-0525

Abstract

The diarrheal disease "cholera" is caused by Vibrio cholerae, and is primarily confined to endemic regions, mostly in Africa and Asia. It is punctuated by outbreaks and creates severe challenges to public health. The disease-causing strains are most-often members of serogroups O1 and O139. PCR-based methods allow rapid diagnosis of these pathogens, including the identification of their biotypes. However, this necessitates the selection of specific target sequences to differentiate even the closely related biotypes of V. cholerae. Oligonucleotides for selective amplification of small RNA (sRNA) genes that are specific to these V. cholerae subtypes were designed. The resulting multiplex PCR assay was validated using V. cholerae cultures (i.e., 19 V. cholerae and 22 non-V. cholerae isolates) and spiked stool samples. The validation using V. cholerae cultures and spiked stool suspensions revealed detection limits of 10-100 pg DNA per reaction and 1.5 cells/mL suspension, respectively. The multiplex PCR assay that targets sRNA genes for amplification enables the sensitive and specific detection, as well as the differentiation of V. cholerae-O1 classical, O1 El Tor, and O139 biotypes. Most importantly, the assay enables fast and cheaper diagnosis compared with classic culture-based methods.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.